Skip to main content

Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA

Philadelphia-area life sciences news this week includes updates on a potential new pain medicine, a gene therapy candidate, and a key patent.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.